UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Radiotherapy and oncology, ISSN 0167-8140, 2017, Volume 124, Issue 3, pp. 513 - 520
Hematology, Oncology and Palliative Medicine | Hypoxia-activated prodrug | HX4 PET | Rat rhabdomyosarcoma | Dose-painting | Growth delay | Radiotherapy | TH-302 | NECK-CANCER PATIENTS | NUDE-MICE | PROGNOSTIC VALUE | LUNG-CANCER | PHASE-I TRIAL | ACTIVATED PRODRUG TH-302 | SQUAMOUS-CELL CARCINOMA | INTERNATIONAL MULTICENTER | LOCAL-CONTROL | FRACTIONATED-IRRADIATION | Radiotherapy Dosage | Humans | Rats | Rhabdomyosarcoma - pathology | Male | Tumor Burden | Rhabdomyosarcoma - diagnostic imaging | Positron Emission Tomography Computed Tomography | Rhabdomyosarcoma - radiotherapy | Animals | Nitroimidazoles - therapeutic use | Phosphoramide Mustards - therapeutic use | Radiotherapy Planning, Computer-Assisted | Radiation | Tumors | Pets | Tracers (Biology) | Index Medicus
Journal Article
Frontiers in oncology, ISSN 2234-943X, 05/2020, Volume 10, pp. 770 - 770
COMPLEX I | CELLS | OXIDATIVE STRESS | HIF-1 alpha | mtDNA | mitochondria | OXPHOS | CANCER | SIRT3 | HETEROGENEITY | HIF-1 | CAIX | GENE | ROS | Metformin | Life Sciences & Biomedicine | Oncology | Science & Technology | HIF-1α
Journal Article
Cancers, ISSN 2072-6694, 06/2020, Volume 12, Issue 6, p. 1585
temozolomide | CT imaging | CELLS | targeted radiotherapy | INFILTRATING LYMPHOCYTES | orthotopic models | bioluminescence imaging | standard of care | HYPOXIA | glioblastoma | THERAPY | MICE | RADIOTHERAPY | PROGRESSION | Life Sciences & Biomedicine | Oncology | Science & Technology | Neuroimaging | Invasiveness | Brain tumors | Brain cancer | Glioblastoma | Radiation therapy | Survival | Glioblastoma multiforme | Animals | Computed tomography | Medical prognosis | Hypoxia | Clinical medicine | Planning | Temozolomide | Tumors
Journal Article
Scientific reports, ISSN 2045-2322, 02/2016, Volume 6, Issue 1, pp. 22198 - 22198
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Neoplasms - metabolism | Gene Expression | Reproducibility of Results | Matrix Metalloproteinase 2 - metabolism | Tumor Microenvironment | Molecular Imaging - methods | Neoplasms - diagnosis | Integrin alphaVbeta3 - metabolism | Mice, Knockout | Matrix Metalloproteinase 2 - genetics | Animals | Heterografts | Integrin alphaVbeta3 - genetics | Neoplasms - genetics | Antibodies - immunology | Cell Line, Tumor | Mice | Enzyme Activation | Matrix Metalloproteinase 2 - immunology | Optical Imaging - methods | Disease Models, Animal | Lysates | Angiogenesis | Animal models | Gelatin | Tumorigenesis | Metalloproteinase | Matrix metalloproteinase | Tumors | Gelatinase A | Index Medicus
Journal Article
Journal of medicinal chemistry, ISSN 0022-2623, 07/2016, Volume 59, Issue 13, pp. 6431 - 6443
Journal Article
Radiotherapy and oncology, ISSN 0167-8140, 12/2019, Volume 141, pp. 247 - 255
Therapeutic index | Radiotherapy | Long-term lung fibrosis | TH-302 | Esophageal cancer | Short-term gut toxicity | TOTAL-BODY IRRADIATION | TUMOR HYPOXIA | HYPOXIA-ACTIVATED PRODRUG | DOXORUBICIN | INJURY | COMBINATION | CANCER | PRO-DRUG TH-302 | PHASE-I | Oncology | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Nitroimidazoles - pharmacology | Phosphoramide Mustards - pharmacology | Humans | Radiation-Sensitizing Agents - pharmacology | Male | Esophageal Neoplasms - radiotherapy | Nitroimidazoles - adverse effects | Animals | Phosphoramide Mustards - adverse effects | Squamous Cell Carcinoma of Head and Neck - radiotherapy | Cell Line, Tumor | Female | Mice | Adenocarcinoma - radiotherapy | Index Medicus
Journal Article
Clinical cancer research, ISSN 1078-0432, 07/2015, Volume 21, Issue 13, pp. 2984 - 2992
Life Sciences & Biomedicine | Oncology | Science & Technology | Nitroimidazoles - pharmacology | Phosphoramide Mustards - pharmacology | Rats | Treatment Outcome | Antineoplastic Agents - therapeutic use | Lung Neoplasms - therapy | Positron-Emission Tomography | Chemoradiotherapy | Cell Hypoxia | Xenograft Model Antitumor Assays | Carcinoma, Non-Small-Cell Lung - therapy | Animals | Imidazoles | Nitroimidazoles - therapeutic use | Phosphoramide Mustards - therapeutic use | Triazoles | Lung Neoplasms - diagnostic imaging | Antineoplastic Agents - pharmacology | Carcinoma, Non-Small-Cell Lung - diagnostic imaging | Radiopharmaceuticals | Index Medicus
Journal Article
Frontiers in oncology, ISSN 2234-943X, 05/2020
Journal Article
Lung cancer (Amsterdam, Netherlands), ISSN 0169-5002, 12/2018, Volume 126, pp. 32 - 40
Journal Article
Radiotherapy and oncology, ISSN 0167-8140, 2013, Volume 108, Issue 3, pp. 523 - 528
Hematology, Oncology and Palliative Medicine | Sulfamide | Carbonic anhydrase IX (CAIX) | 5-Nitroimidazole | Radiotherapy | Dual targeting | Carbonic Anhydrases - physiology | Animals | Nitroimidazoles - pharmacology | Antigens, Neoplasm - physiology | Humans | Radiation-Sensitizing Agents - pharmacology | Colorectal Neoplasms - radiotherapy | Cell Line, Tumor | Mice | Carbonic Anhydrase Inhibitors - pharmacology | Carbonic Anhydrase IX | Health aspects | Tumors | Index Medicus
Journal Article
Frontiers in oncology, ISSN 2234-943X, 05/2020, Volume 10
COMPLEX I | CELLS | OXIDATIVE STRESS | HIF-1 alpha | mtDNA | mitochondria | OXPHOS | CANCER | SIRT3 | HETEROGENEITY | HIF-1 | CAIX | GENE | ROS | Metformin
Journal Article
Lung cancer (Amsterdam, Netherlands), ISSN 0169-5002, 12/2018, Volume 126, pp. 32 - 40
Glycolysis | Radiotherapy | Metabolic inhibition | Glutamine metabolism | Non-small cell lung cancer | Respiratory System | Oncology | Life Sciences & Biomedicine | Science & Technology | Glucose metabolism | Squamous cell carcinoma | Radiation | Physiological aspects | Lung cancer, Small cell | Glucose | Lung cancer, Non-small cell | Cells | Dextrose | Glutamine
Journal Article
Radiotherapy and oncology, ISSN 0167-8140, 2015, Volume 116, Issue 3, pp. 438 - 442
Hematology, Oncology and Palliative Medicine | ED-B | MHCI | Immunotherapy | Cancer | Drug Administration Schedule | Recombinant Fusion Proteins - pharmacology | Combined Modality Therapy | Antineoplastic Agents - administration & dosage | Mice, Inbred Strains | Fibronectins - metabolism | Histocompatibility Antigens Class I - metabolism | Immunity, Cellular - immunology | Animals | Neoplasms - immunology | Killer Cells, Natural - immunology | Radioimmunotherapy - methods | Neoplasms - radiotherapy | Antineoplastic Agents - pharmacology | Mice | Recombinant Fusion Proteins - administration & dosage | Disease Models, Animal | Killer cells | Radiotherapy | Analysis | Tumors | Index Medicus
Journal Article
Radiotherapy and oncology, ISSN 0167-8140, 2015, Volume 116, Issue 3, pp. 352 - 357
Hematology, Oncology and Palliative Medicine | Therapy | Hypoxia | Carbonic anhydrase IX | Window-of-opportunity trial | Imaging | Hypoxia - physiopathology | Positron-Emission Tomography | Neoplasms - physiopathology | Hypoxia - diagnostic imaging | Neoplasms - diagnostic imaging | Humans | Tumors | Index Medicus
Journal Article
Clinical cancer research, ISSN 1078-0432, 12/2015, Volume 21, Issue 24, pp. 5511 - 5518